Bnp Paribas Asset Management Holding S.A. Biomarin Pharmaceutical Inc Transaction History

Bnp Paribas Asset Management Holding S.A.

  • $41 Billion
  • Q2 2025

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 223,391 shares of BMRN stock, worth $12.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
223,391
Previous 134,248 66.4%
Holding current value
$12.8 Million
Previous $9.5 Million 29.24%
% of portfolio
0.03%
Previous 0.03%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
BUY
$54.08 - $68.32 $4.82 Million - $6.09 Million
89,143 Added 66.4%
223,391 $12.3 Million
Q1 2025

May 13, 2025
BUY
$61.25 - $72.83 $51,450 - $61,177
840 Added 0.63%
134,248 $9.5 Million
Q4 2024

Feb 11, 2025
SELL
$61.93 - $70.49 $1.29 Million - $1.46 Million
-20,755 Reduced 13.46%
133,408 $8.77 Million
Q3 2024

Nov 08, 2024
SELL
$69.02 - $93.84 $27 Million - $36.7 Million
-390,933 Reduced 71.72%
154,163 $10.8 Million
Q2 2024

Jul 29, 2024
SELL
$74.43 - $92.22 $18.8 Million - $23.3 Million
-252,669 Reduced 31.67%
545,096 $44.9 Million
Q1 2024

May 08, 2024
BUY
$83.81 - $99.0 $39.1 Million - $46.2 Million
466,544 Added 140.86%
797,765 $69.7 Million
Q4 2023

Feb 09, 2024
SELL
$76.22 - $98.51 $19.6 Million - $25.4 Million
-257,722 Reduced 43.76%
331,221 $31.9 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $34 Million - $37.8 Million
400,055 Added 211.79%
588,943 $52.1 Million
Q2 2023

Aug 08, 2023
BUY
$86.68 - $100.3 $778,733 - $901,095
8,984 Added 4.99%
188,888 $16.4 Million
Q1 2023

May 08, 2023
BUY
$87.74 - $117.27 $6.05 Million - $8.09 Million
68,965 Added 62.16%
179,904 $17.5 Million
Q4 2022

Feb 09, 2023
SELL
$80.93 - $108.63 $4.88 Million - $6.55 Million
-60,275 Reduced 35.2%
110,939 $11.5 Million
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $3.15 Million - $3.72 Million
-38,380 Reduced 18.31%
171,214 $14.5 Million
Q2 2022

Aug 04, 2022
SELL
$71.48 - $86.85 $413,511 - $502,427
-5,785 Reduced 2.69%
209,594 $17.4 Million
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $1.92 Million - $2.39 Million
25,833 Added 13.63%
215,379 $16.6 Million
Q4 2021

Feb 09, 2022
BUY
$71.72 - $91.47 $159,218 - $203,063
2,220 Added 1.19%
189,546 $16.7 Million
Q3 2021

Nov 08, 2021
BUY
$74.77 - $85.47 $2.63 Million - $3 Million
35,133 Added 23.08%
187,326 $14.5 Million
Q2 2021

Aug 05, 2021
BUY
$75.51 - $84.79 $797,687 - $895,721
10,564 Added 7.46%
152,193 $12.7 Million
Q1 2021

May 05, 2021
BUY
$74.73 - $90.69 $854,014 - $1.04 Million
11,428 Added 8.78%
141,629 $10.7 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $2.86 Million - $3.56 Million
-39,447 Reduced 23.25%
130,201 $11.4 Million
Q3 2020

Nov 09, 2020
BUY
$71.87 - $131.03 $5.29 Million - $9.64 Million
73,578 Added 76.59%
169,648 $12.9 Million
Q2 2020

Aug 04, 2020
SELL
$79.55 - $124.22 $3.74 Million - $5.83 Million
-46,963 Reduced 32.83%
96,070 $11.8 Million
Q1 2020

May 12, 2020
SELL
$71.37 - $96.85 $204,903 - $278,056
-2,871 Reduced 1.97%
143,033 $12.1 Million
Q4 2019

Feb 11, 2020
BUY
$64.27 - $86.37 $962,314 - $1.29 Million
14,973 Added 11.44%
145,904 $12.3 Million
Q3 2019

Nov 12, 2019
BUY
$67.4 - $85.11 $840,815 - $1.06 Million
12,475 Added 10.53%
130,931 $8.83 Million
Q2 2019

Aug 02, 2019
SELL
$80.35 - $93.9 $2.27 Million - $2.66 Million
-28,282 Reduced 19.27%
118,456 $10.1 Million
Q1 2019

Apr 26, 2019
BUY
$84.2 - $98.62 $3.28 Million - $3.84 Million
38,968 Added 36.16%
146,738 $13 Million
Q4 2018

Feb 13, 2019
SELL
$80.14 - $106.07 $1.81 Million - $2.39 Million
-22,557 Reduced 17.31%
107,770 $9.01 Million
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $14.1 Million - $15.9 Million
-150,451 Reduced 53.58%
130,327 $12.6 Million
Q2 2018

Aug 01, 2018
SELL
$76.01 - $99.03 $651,101 - $848,290
-8,566 Reduced 2.96%
280,778 $26.4 Million
Q1 2018

May 07, 2018
BUY
$77.67 - $92.63 $293,204 - $349,678
3,775 Added 1.32%
289,344 $23.5 Million
Q4 2017

Feb 01, 2018
BUY
$80.76 - $95.13 $5.14 Million - $6.05 Million
63,631 Added 28.67%
285,569 $25.5 Million
Q3 2017

Nov 02, 2017
BUY
$80.6 - $94.95 $17.9 Million - $21.1 Million
221,938
221,938 $20.7 Million

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
187M
Call Options Held
1.25M
Put Options Held
992K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.7B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bnp Paribas Asset Management Holding S.A. Portfolio

Follow Bnp Paribas Asset Management Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email